Liver, and potential use in Breast & Lung Cancer treatment.
This market cap should be MUCH higher. I know it's had a good quarter, but the fact of the matter is CLSN should never have lived in the $2-$3 range.
Thermodox is smacking these tumors in a GOOD way. HEAT Trials/Data should show this. I think a # of Oncologists realize this is the FUTURE.
I'm absolutely floored that very little realize the potential here. This is not an efficient market IMO. Revenues could be 1-2B annually.
Do your DD ; This stock is going much higher IMHO.